Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

NCT00980889 is registered in ClinicalTrials.gov with Stockholm South General Hospital as lead sponsor.

NCT NCT00980889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00980889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction
Lead sponsor
Stockholm South General Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
May 31, 2013
Enrollment
400 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasms, pancreatic neoplasms, stent occlusion